Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Evaluate different IRA types for index fund fees, focusing on overall costs and long-term value to choose the best option.
25,891 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
NATO members are accelerating tank modernization, drawing investor focus to defense-name stocks. Markets weigh how ta...
Planet Labs reports a record Q4 revenue and a backlog eclipsing annual sales, spurring a sharp after hours rally as i...
As Uniti maps out its path for 2026, investors want clarity on revenue, cash flow, and growth prospects. This guide b...
A major new stake in Virtu Financial is drawing attention from investors. This guide explains the numbers behind the ...
Senator Lummis frames Bitcoin as a hedge against mounting U.S. debt as the CLARITY Act moves closer to a Senate floor...
A top Deutsche Bank economist warns that AI’s productivity gains may take years to materialize. If returns lag, risin...
A pivotal license extension in Ghana fuels a surge in Kosmos Energy. This article breaks down what the move means for...
Binance filed a defamation lawsuit against The Wall Street Journal in New York, challenging a February report on Iran...
Long-term wealth isn’t built on quick trades. It comes from steady income and durable growth. Here are two monster di...
A single headline about 500 million barrels can spark fear or opportunity in oil investing. This article unpacks what...
A speculative AI forecast, branded as Altman ChatGPT, points to a sharp XRP rally by the end of June 2026 as institut...